FDA encourages the use of Drug Master Files (DMFs) and highlights quality considerations that have been issued recently in guidance to further support cannabis research. Cannabis related firms will learn how DMFs might be able to help address their concerns related to the disclosure of potentially proprietary information.
Speaker:
Cassandra Taylor, Ph.D.
Chemist, Botanical Review Team
Office of Pharmaceutical Quality | CDER | FDA
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: [ Ссылка ]
CDER SBIA 2020 Playlist: [ Ссылка ]
LinkedIn: [ Ссылка ]
Training resources: [ Ссылка ]
Twitter: [ Ссылка ]
CDER small business e-mail update subscription: [ Ссылка ]
Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
